Baharaff Allen 13D/13G Filings for Galmed Pharmaceuticals Ltd. (GLMD)

Baharaff Allen 13D and 13G filings for Galmed Pharmaceuticals Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-18
4:15 pm
Purchase
2024-12-3113GGALMED PHARMACEUTICALS LTD SHS
GLMD
Baharaff Allen44,128
2.600%
17,669increase
(+66.78%)
Filing